Also, the RPL30 driven p53 activation occurs through MDM2, a negative regulator of p53 which correlates with cardiomyocyte hypertrophy and apoptosis in end stage human heart failure (Mak et al. 2017). This evidence concerns the gene MDM2 and heart failure.